Retrospective Study of Clinical Practice and Management of Imported Schistosomiasis in France

Completed

• Conditions: Schistosomiasis

• Registration Number: NCT04810741
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

Schistosomiasis is a major public health issue. Clinical guidelines for the management of imported schistosomiasis are heterogeneous. The objective of this study is to describe the clinical management of schistosomiasis imported cases in France, regarding diagnosis, treatment and follow-up.

Detailed Description

Schistosomiasis is a major public health issue. Clinical guidelines for the management of imported schistosomiasis are heterogeneous. The objective of this study is to describe the clinical management of schistosomiasis imported cases in France, regarding diagnosis, treatment and follow-up. It is a multicentric, retrospective, descriptive study. Inclusion criteria are an age ≥ 18, a positive western blot and / or a positive microscopy exam. Data concerning clinical presentation, biological samples, imaging, treatment and follow-up will be assessed. A descriptive analysis will be performed.

Study Timeline

• Status Verified: 2021-03
• Study First Submitted: 2021-03-19
• Study First Submitted QC: 2021-03-19
• Study First Posted: 2021-03-23
• Study Start: 2021-12-21
• Primary Completion: 2022-05-18
• Study Completion: 2022-05-18
• Last Update Submitted: 2023-01-12
• Last Update Posted: 2023-01-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 532

Inclusion Criteria

• Age ≥ 18, positive schistosomiasis immunoblot and / or positive microscopy examination for schistosomiasis eggs

Exclusion Criteria

• • patients under guardianship

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Describe the management of patients with chronic schistosomiasis in France, in terms of diagnosis, assessment, management and follow-up.	12 months	Draft of new clarified recommendations on the overall management of this pathology

Trial Locations

Locations (1)

hospital BICETRE; 🇫🇷 Le Kremlin-Bicêtre, France